The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
DNA Vaccines—How Far From Clinical Use?
Open accessAbstract
Two decades ago successful transfection of antigen presenting cells (APC) in vivo was demonstrated which resulted in the induction of primary adaptive immune responses. Due to the good biocompatibility of plasmid DNA, their cost-efficient production and long shelf life, many researchers aimed to develop DNA vaccine-based immunotherapeutic strategies for treatment of infections and cancer, but also autoimmune diseases and allergies. This review aims to summarize our current knowledge on the course of action of DNA vaccines, and which factors are responsible for the poor immunogenicity in human so far. Important optimization steps that improve DNA transfection efficiency comprise the introduction of DNA-complexing nano-carriers aimed to prevent extracellular DNA degradation, enabling APC targeting, and enhanced endo/lysosomal escape of DNA. Attachment of virus-derived nuclear localization sequences facilitates nuclear entry of DNA. Improvements in DNA vaccine design include the use of APC-specific promotors for transcriptional targeting, the arrangement of multiple antigen sequences, the co-delivery of molecular adjuvants to prevent tolerance induction, and strategies to circumvent potential inhibitory effects of the vector backbone. Successful clinical use of DNA vaccines may require combined employment of all of these parameters, and combination treatment with additional drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“To this end, antigen-encoding vaccines have been coadministered with established adjuvants like aluminium salt-based Alum [82] or immunostimulatory CpG oligonucleotides which engage the endosomal located toll-like receptor (TLR)9 to stimulate APC [83].”
BackgroundLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
Kim, J. H., Lee, S.-R., Li, L.-H., Park, H.-J., Park, J.-H., Lee, K. Y., Kim, M.-K., Shin, B. A., & Choi, S.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018556 · Cited by 1,338
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,048
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine
Wang, R., Doolan, D. L., Le, T. P., Hedstrom, R. C., Coonan, K. M., Charoenvit, Y., Jones, T. R., Hobart, P., Margalith, M., Ng, J., et al. (1998) · Science · doi:10.1126/science.282.5388.476 · Cited by 833
Tang, M., & Szoka, F. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300454 · Cited by 814
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
(1968) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/41.2.351 · Cited by 775
IL‐12 and IL‐23: master regulators of innate and adaptive immunity
Langrish, C. L., McKenzie, B. S., Wilson, N. J., De Waal Malefyt, R., Kastelein, R. A., & Cua, D. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00214.x · Cited by 753
Long-term persistence of plasmid DNA and foreign gone expression in mouse muscle
Wolff, J. A., Ludtke, J. J., Acsadi, G., Williams, P., & Jani, A. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.363 · Cited by 738
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Zhang, P., Sun, F., Liu, S., & Jiang, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.040 · Cited by 688
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Lohcharoenkal, W., Wang, L., Chen, Y. C., & Rojanasakul, Y. (2014) · BioMed Research International · doi:10.1155/2014/180549 · Cited by 655
Unraveling the mysteries of serum albumin—more than just a serum protein
Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00299 · Cited by 641
MacGregor, R. R., Boyer, J. D., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J., Ciccarelli, R. B., et al. (1998) · Journal of Infectious Diseases · doi:10.1086/515613 · Cited by 640
Niikura, K., Matsunaga, T., Suzuki, T., Kobayashi, S., Yamaguchi, H., Orba, Y., Kawaguchi, A., Hasegawa, H., Kajino, K., Ninomiya, T., et al. (2013) · ACS Nano · doi:10.1021/nn3057005 · Cited by 638
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Spolski, R., Li, P., & Leonard, W. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0046-y · Cited by 637
Receptor-mediated gene delivery and expression in vivo.
Wu, G. Y., & Wu, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68081-0 · Cited by 635
Pathogen recognition and development of particulate vaccines: Does size matter?
Xiang, S. D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P. L., & Plebanski, M. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.016 · Cited by 602
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
Joffre, O., Nolte, M. A., Spörri, R., & Sousa, C. R. E. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00718.x · Cited by 598
The urgent need to recover MHC class I in cancers for effective immunotherapy
Garrido, F., Aptsiauri, N., Doorduijn, E. M., Garcia Lora, A. M., & van Hall, T. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.007 · Cited by 585
Porgador, A., Irvine, K. R., Iwasaki, A., Barber, B. H., Restifo, N. P., & Germain, R. N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1075 · Cited by 560
Metlay, J. P., Witmer-Pack, M. D., Agger, R., Crowley, M. T., Lawless, D., & Steinman, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1753 · Cited by 555
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.014 · Cited by 555
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Weber, R., Fleming, V., Hu, X., Nagibin, V., Groth, C., Altevogt, P., Utikal, J., & Umansky, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01310 · Cited by 538
Erbacher, P., Zou, S., Bettinger, T., Steffan, A.-M., & Remy, J.-S. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981000671 · Cited by 536
Hatakeyama, H., Akita, H., & Harashima, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00059 · Cited by 495
Biologically Targeted Magnetic Hyperthermia: Potential and Limitations
Chang, D., Lim, M., Goos, J. A. C. M., Qiao, R., Ng, Y. Y., Mansfeld, F. M., Jackson, M., Davis, T. P., & Kavallaris, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00831 · Cited by 495
In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes
Li, S., & Huang, L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300482 · Cited by 475
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Appelmelk, B. J., van Die, I., van Vliet, S. J., Vandenbroucke-Grauls, C. M. J. E., Geijtenbeek, T. B. H., & van Kooyk, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1635 · Cited by 431
Adenovirus enhancement of transferrin-polylysine-mediated gene delivery.
Curiel, D. T., Agarwal, S., Wagner, E., & Cotten, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8850 · Cited by 423
Lu, Y.-C., Yao, X., Crystal, J. S., Li, Y. F., El-Gamil, M., Gross, C., Davis, L., Dudley, M. E., Yang, J. C., Samuels, Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0433 · Cited by 401
Jiang, Y., Huo, S., Mizuhara, T., Das, R., Lee, Y.-W., Hou, S., Moyano, D. F., Duncan, B., Liang, X.-J., & Rotello, V. M. (2015) · ACS Nano · doi:10.1021/acsnano.5b03521 · Cited by 401
Tumor-Associated Macrophages: Implications in Cancer Immunotherapy
Petty, A. J., & Yang, Y. (2017) · Immunotherapy · doi:10.2217/imt-2016-0135 · Cited by 363
Interleukin-15 biology and its therapeutic implications in cancer
Steel, J. C., Waldmann, T. A., & Morris, J. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.004 · Cited by 361
Advances in Non-Viral DNA Vectors for Gene Therapy
Hardee, C., Arévalo-Soliz, L., Hornstein, B., & Zechiedrich, L. (2017) · Genes · doi:10.3390/genes8020065 · Cited by 356
Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine.
Laemmli, U. K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4288 · Cited by 354
Intracellular routing of plasmid DNA during non-viral gene transfer
LECHARDEUR, D., VERKMAN, A., & LUKACS, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.008 · Cited by 340
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
Dupuis, M., Denis-Mize, K., Woo, C., Goldbeck, C., Selby, M. J., Chen, M., Otten, G. R., Ulmer, J. B., Donnelly, J. J., Ott, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2850 · Cited by 327
Wang, Z., Troilo, P. J., Wang, X., Griffiths, T. G., Pacchione, S. J., Barnum, A. B., Harper, L. B., Pauley, C. J., Niu, Z., Denisova, L., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302213 · Cited by 322
Scheiermann, J., & Klinman, D. M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.065 · Cited by 322
Singh, D. P., Herrera, C. E., Singh, B., Singh, S., Singh, R. K., & Kumar, R. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2018.01.004 · Cited by 313
Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier
Zhou, T., Zhou, X., & Xing, D. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.044 · Cited by 310
Immuno-Oncology: Emerging Targets and Combination Therapies
Marshall, H. T., & Djamgoz, M. B. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00315 · Cited by 301
Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
Yang, J., Bahreman, A., Daudey, G., Bussmann, J., Olsthoorn, R. C. L., & Kros, A. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00172 · Cited by 299
Burgdorf, S., Lukacs-Kornek, V., & Kurts, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6770 · Cited by 295
Engineering Nanoparticle-Coated Bacteria as Oral DNA Vaccines for Cancer Immunotherapy
Hu, Q., Wu, M., Fang, C., Cheng, C., Zhao, M., Fang, W., Chu, P. K., Ping, Y., & Tang, G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b00570 · Cited by 286
Gene Therapies for Cancer: Strategies, Challenges and Successes
Das, S. K., Menezes, M. E., Bhatia, S., Wang, X., Emdad, L., Sarkar, D., & Fisher, P. B. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24791 · Cited by 284
Direct Gene Transfer into Nonhuman Primate Myofibers In Vivo
Jiao, S., Williams, P., Berg, R. K., Hodgeman, B. A., Liu, L., Repetto, G., & Wolff, J. A. (1992) · Human Gene Therapy · doi:10.1089/hum.1992.3.1-21 · Cited by 283
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Selby, L. I., Cortez‐Jugo, C. M., Such, G. K., & Johnston, A. P. R. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 283
Kreiss, P. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.19.3792 · Cited by 279
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery
Mody, K. T., Popat, A., Mahony, D., Cavallaro, A. S., Yu, C., & Mitter, N. (2013) · Nanoscale · doi:10.1039/c3nr00357d · Cited by 261
Cytokine gene expression in epidermis with biological effects following injection of naked DNA
Hengge, U. R., Chan, E. F., Foster, R. A., Walker, P. S., & Vogel, J. C. (1995) · Nature Genetics · doi:10.1038/ng0695-161 · Cited by 253
Iwasaki, A., Torres, C. A., Ohashi, P. S., Robinson, H. L., & Barber, B. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.11 · Cited by 245
Suschak, J. J., Williams, J. A., & Schmaljohn, C. S. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1330236 · Cited by 240
Polysaccharides as vaccine adjuvants
Sun, B., Yu, S., Zhao, D., Guo, S., Wang, X., & Zhao, K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.040 · Cited by 238
Dendritic cells and other innate determinants of T helper cell polarisation
Walsh, K. P., & Mills, K. H. G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.07.006 · Cited by 236
Sequence Requirements for Plasmid Nuclear Import
Dean, D. A., Dean, B. S., Muller, S., & Smith, L. C. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4716 · Cited by 234
Liu, Q., Chen, X., Jia, J., Zhang, W., Yang, T., Wang, L., & Ma, G. (2015) · ACS Nano · doi:10.1021/nn5066793 · Cited by 233
Cancer nanomedicine: is targeting our target?
Lammers, T., Kiessling, F., Ashford, M., Hennink, W., Crommelin, D., & Storm, G. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.69 · Cited by 233
Carbon nanotubes from synthesis to in vivo biomedical applications
Sajid, M. I., Jamshaid, U., Jamshaid, T., Zafar, N., Fessi, H., & Elaissari, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.064 · Cited by 230
Allen, T. M., Hansen, C. B., & Guo, L. S. S. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90115-g · Cited by 228
Blackman, L. D., Varlas, S., Arno, M. C., Houston, Z. H., Fletcher, N. L., Thurecht, K. J., Hasan, M., Gibson, M. I., & O’Reilly, R. K. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00168 · Cited by 226
Cytoplasmic transport and nuclear import of plasmid DNA
Bai, H., Lester, G. M. S., Petishnok, L. C., & Dean, D. A. (2017) · Bioscience Reports · doi:10.1042/bsr20160616 · Cited by 210
Itaka, K., Harada, A., Yamasaki, Y., Nakamura, K., Kawaguchi, H., & Kataoka, K. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.470 · Cited by 201
Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
Rezaee, M., Oskuee, R. K., Nassirli, H., & Malaekeh-Nikouei, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.023 · Cited by 200 · cited 1×
“Cationic lipids are generally very suitable for transfection as they preferably interact with the anionic cell membrane thus facilitating uptake of the transfection complex into the cell [173].”
BackgroundCleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells
Chng, J., Wang, T., Nian, R., Lau, A., Hoi, K. M., Ho, S. C., Gagnon, P., Bi, X., & Yang, Y. (2015) · mAbs · doi:10.1080/19420862.2015.1008351 · Cited by 196
Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection
Cohen, R. N., van der Aa, M. A. E. M., Macaraeg, N., Lee, A. P., & Szoka, F. C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.016 · Cited by 194
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination
Slütter, B., Plapied, L., Fievez, V., Alonso Sande, M., des Rieux, A., Schneider, Y.-J., Van Riet, E., Jiskoot, W., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.011 · Cited by 192
Stéen, E. J. L., Edem, P. E., Nørregaard, K., Jørgensen, J. T., Shalgunov, V., Kjaer, A., & Herth, M. M. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.021 · Cited by 189
West Nile virus: Recent trends in diagnosis and vaccine development
Dauphin, G., & Zientara, S. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.005 · Cited by 188
den Haan, J. M. M., Arens, R., & van Zelm, M. C. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.011 · Cited by 185
Manam, S., Ledwith, B. J., Barnum, A. B., Troilo, P. J., Pauley, C. J., Harper, L. B., Griffiths II, T. G., Niu, Z., Denisova, L., Follmer, T. T., et al. (2000) · Intervirology · doi:10.1159/000053994 · Cited by 183
Mincheff, M., Tchakarov, S., Zoubak, S., Loukinov, D., Botev, C., Altankova, I., Georgiev, G., Petrov, S., & Meryman, H. T. (2000) · European Urology · doi:10.1159/000020281 · Cited by 183
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
Macri, C., Dumont, C., Johnston, A. P., & Mintern, J. D. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.6 · Cited by 182
Peng, L.-H., Huang, Y.-F., Zhang, C.-Z., Niu, J., Chen, Y., Chu, Y., Jiang, Z.-H., Gao, J.-Q., & Mao, Z.-W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.057 · Cited by 178
Chen, Y.-S., Hung, Y.-C., Lin, W.-H., & Huang, G. S. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/19/195101 · Cited by 176
Immune suppression and reversal of the suppressive tumor microenvironment
Shimizu, K., Iyoda, T., Okada, M., Yamasaki, S., & Fujii, S. (2018) · International Immunology · doi:10.1093/intimm/dxy042 · Cited by 170
Nanomaterial-Enabled Cancer Therapy
Quader, S., & Kataoka, K. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.026 · Cited by 165
Ariizumi, K., Shen, G.-L., Shikano, S., Ritter, R., Zukas, P., Edelbaum, D., Morita, A., & Takashima, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11957 · Cited by 164
Han, J., Wang, Q., Zhang, Z., Gong, T., & Sun, X. (2014) · Small · doi:10.1002/smll.201301992 · Cited by 164
Magnetic nanoparticles: A multifunctional vehicle for modern theranostics
Angelakeris, M. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.02.022 · Cited by 164
Nanomedicines for the treatment of hematological malignancies
Deshantri, A. K., Varela-Moreira, A., Ecker, V., Mandhane, S. N., Schiffelers, R. M., Buchner, M., & Fens, M. H. A. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.034 · Cited by 159
Zuhorn, I. S., & Hoekstra, D. (2002) · The Journal of Membrane Biology · doi:10.1007/s00232-002-1015-7 · Cited by 156
The Interaction of Human Pathogenic Fungi With C-Type Lectin Receptors
Goyal, S., Castrillón-Betancur, J. C., Klaile, E., & Slevogt, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01261 · Cited by 150
MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity
Self-Fordham, J., Naqvi, A. R., Uttamani, J. R., Kulkarni, V., & Nares, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01062 · Cited by 148
Rottinghaus, S. T., Poland, G. A., Jacobson, R. M., Barr, L. J., & Roy, M. J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00447-x · Cited by 147
The opposing roles of CD 4+ T cells in anti‐tumour immunity
Ahrends, T., & Borst, J. G. (2018) · Immunology · doi:10.1111/imm.12941 · Cited by 146
Luo, Z., Wang, C., Yi, H., Li, P., Pan, H., Liu, L., Cai, L., & Ma, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.050 · Cited by 142
Saadé, F., Honda‐Okubo, Y., Trec, S., & Petrovsky, N. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.077 · Cited by 141
Adjuvant formulations for virus-like particle (VLP) based vaccines
Cimica, V., & Galarza, J. M. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.08.004 · Cited by 140
Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
Jorritsma, S. H. T., Gowans, E. J., Grubor‐Bauk, B., & Wijesundara, D. K. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.062 · Cited by 137
The present status and future prospects of peptide-based cancer vaccines
Hirayama, M., & Nishimura, Y. (2016) · International Immunology · doi:10.1093/intimm/dxw027 · Cited by 135
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma
Tagawa, S. T., Lee, P. P., Snively, J., Boswell, W. D., Ounpraseuth, S., Lee, S., Hickingbottom, B., Smith, J. W., Johnson, D. L., & Weber, J. S. (2003) · Cancer · doi:10.1002/cncr.11462 · Cited by 134
Blank, F., Stumbles, P. A., Seydoux, E., Holt, P. G., Petri‐Fink, A., Rothen‐Rutishauser, B., Strickland, D. H., & von Garnier, C. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0387oc · Cited by 134
Targeting myeloid cells in the tumor sustaining microenvironment
Schupp, J., Krebs, F. K., Zimmer, N., Trzeciak, E. R., Schuppan, D., & Tuettenberg, A. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.013 · Cited by 134
DNA Nanotechnology for Precise Control over Drug Delivery and Gene Therapy
Angell, C., Xie, S., Zhang, L., & Chen, Y. (2016) · Small · doi:10.1002/smll.201502167 · Cited by 132
Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery
Lin, I. Y. C., Van, T. T. H., & Smooker, P. M. (2015) · Vaccines · doi:10.3390/vaccines3040940 · Cited by 129
Alvarez, R. D., Huh, W. K., Bae, S., Lamb, L. S., Conner, M., Boyer, J., Wang, C., Hung, C., Sauter, E., Paradis, M., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.11.026 · Cited by 126
Gracey, L. E., Maniar, J. M., Chen, Z.-Y., Lu, J., Fire, A. Z., & Kay, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.244 · Cited by 124
Cytotoxic T Cell Responses to DNA Vaccination: Dependence on Antigen Presentation via Class II MHC
Maecker, H. T., Umetsu, D. T., DeKruyff, R. H., & Levy, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6532 · Cited by 124
Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells
Yagi, M., Miyamoto, T. K., Toyama, Y., & Suda, T. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0697-9 · Cited by 121
Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option
Wang, M., Gao, Z., Zhang, Y., & Pan, L. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7557-x · Cited by 121
Dane, K. Y., Nembrini, C., Tomei, A. A., Eby, J. K., O’Neil, C. P., Velluto, D., Swartz, M. A., Inverardi, L., & Hubbell, J. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.009 · Cited by 109
Liposomal adjuvants for human vaccines
Alving, C. R., Beck, Z., Matyas, G. R., & Rao, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1151871 · Cited by 108
Luo, X., Peng, X., Hou, J., Wu, S., Shen, J., & Wang, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s137245 · Cited by 108
Cardarelli, F., Pozzi, D., Bifone, A., Marchini, C., & Caracciolo, G. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200374e · Cited by 104
TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells
Peng, L., Niu, J., Zhang, C., Yu, W., Wu, J., Shan, Y.-H., Wang, X.-R., Shen, Y., Mao, Z., Liang, W., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.062 · Cited by 103
Grandinetti, G., Ingle, N. P., & Reineke, T. M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200078n · Cited by 102
Combinatorial Nano–Bio Interfaces
Cai, P., Zhang, X., Wang, M., Wu, Y., & Chen, X. (2018) · ACS Nano · doi:10.1021/acsnano.8b03285 · Cited by 102
Towards the development of human immune-system-on-a-chip platforms
Polini, A., del Mercato, L. L., Adriano Barra, A., Zhang, Y. S., Calabi, F., & Gigli, G. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.10.003 · Cited by 101
Nucleocytoplasmic transport of plasmid DNA: a perilous journey from the cytoplasm to the nucleus
Lechardeur, D., & Lukacs, G. L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.882 · Cited by 99
Cancer immunology and canine malignant melanoma: A comparative review
Atherton, M. J., Morris, J. S., McDermott, M. R., & Lichty, B. D. (2015) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2015.11.003 · Cited by 99
Karimi, M., Avci, P., Mobasseri, R., Hamblin, M. R., & Naderi‐Manesh, H. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1651-0 · Cited by 97
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Tiptiri-Kourpeti, A., Spyridopoulou, K., Pappa, A., & Chlichlia, K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.05.004 · Cited by 96
Rádis‐Baptista, G., Campelo, I. S., Morlighem, J.-É. R. L., Melo, L. M., & Freitas, V. J. D. F. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.05.002 · Cited by 96
Osborn, M. J., McElmurry, R. T., Lees, C. J., DeFeo, A. P., Chen, Z.-Y., Kay, M. A., Naldini, L., Freeman, G. J., Tolar, J., & Blazar, B. R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.249 · Cited by 95
Membrane interactions and antimicrobial effects of inorganic nanoparticles
Häffner, S. M., & Malmsten, M. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.07.029 · Cited by 93
Rajapaksa, A. E., Ho, J. J., Qi, A., Bischof, R. J., Nguyen, T., Tate, M. D., Piedrafita, D. M., McIntosh, M. P., Yeo, L. Y., Meeusen, E. N. T., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-60 · Cited by 92
Deng, W., Lira, V., Hudson, T. E., Lemmens, E. E., Hanson, W. G., Flores, R., Barajas, G., Katibah, G. E., Desbien, A. L., Lauer, P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801910115 · Cited by 92
Keeney, M., Ong, S., Padilla-Lopez, A., Yao, Z., Goodman, S. B., Wu, J. C., & Yang, F. (2013) · ACS Nano · doi:10.1021/nn402657d · Cited by 91
Lazzaro, S., Giovani, C., Mangiavacchi, S., Magini, D., Maione, D., Baudner, B. C., Geall, A. J., Gregorio, E. D., D’Oro, U., & Buonsanti, C. (2015) · Immunology · doi:10.1111/imm.12505 · Cited by 91
Skeletal muscle cells: from local inflammatory response to active immunity
Marino, M., Scuderi, F., Provenzano, C., & Bartoccioni, E. (2010) · Gene Therapy · doi:10.1038/gt.2010.124 · Cited by 90
Thomann, L., Käuper, P., Rossi, N., Milona, P., Herrmann, B., & McCullough, K. C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.015 · Cited by 88
TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines
Tudor, D., Dubuquoy, C., Gaboriau‐Routhiau, V., Lefèvre, F., Charley, B., & Riffault, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.09.001 · Cited by 88
A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines
Suschak, J. J., Wang, S., Fitzgerald, K. A., & Lu, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501836 · Cited by 87
The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
Bros, M., Nuhn, L., Simon, J., Moll, L., Mailänder, V., Landfester, K., & Grabbe, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01760 · Cited by 86
Self-citationDNA vaccines, electroporation and their applications in cancer treatment
Lee, S.-H., Danishmalik, S. N., & Sin, J. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1035502 · Cited by 84
Non-identical twins: Different faces of CR3 and CR4 in myeloid and lymphoid cells of mice and men
Erdei, A., Lukácsi, S., Mácsik‐Valent, B., Nagy‐Baló, Z., Kurucz, I., & Bajtay, Z. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.025 · Cited by 84
Ross, R., Jonuleit, H., Bros, M., Ross, X.-L., Enk, A., Knop, J., Reske‐Kunz, A. B., Yamashiro, S., & Matsumura, F. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00112.x · Cited by 83
Self-citationA researcher’s guide to the galaxy of IRESs
Terenin, I. M., Smirnova, V. V., Andreev, D. E., Dmitriev, S. E., & Shatsky, I. N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2409-5 · Cited by 83
DNA and mRNA vaccination against allergies
Scheiblhofer, S., Thalhamer, J., & Weiss, R. (2018) · Pediatric Allergy and Immunology · doi:10.1111/pai.12964 · Cited by 83
Weber, J. S., Boswell, W. D., Smith, J. W., Hersh, E. M., Snively, J., Diaz, M. I., Miles, S., Liu, X., Obrocea, M., Qiu, Z., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181611420 · Cited by 82
Neoepitopes as Cancer Immunotherapy Targets: Key Challenges and Opportunities
Brennick, C. A., George, M. M., Corwin, W. L., Srivastava, P. K., & Ebrahimi-Nik, H. (2017) · Immunotherapy · doi:10.2217/imt-2016-0146 · Cited by 82
Saito, G., Amidon, G. L., & Lee, K.-D. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301859 · Cited by 77
Safety and efficacy of DNA vaccines
Stenler, S., Blomberg, P., & Smith, C. E. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28077 · Cited by 74
Direct transfection and activation of human cutaneous dendritic cells
Larregina, A. T., Watkins, S. C., Erdös, G., Spencer, L. A., Storkus, W. J., Stolz, D. B., & Falo, L. D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301404 · Cited by 74
Shen, L., Tenzer, S., Storck, W., Hobernik, D., Raker, V. K., Fischer, K., Decker, S., Dzionek, A., Krauthäuser, S., Diken, M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.049 · Cited by 74
Self-citationChen, C., Jones, C. H., Mistriotis, P., Yu, Y., Ma, X., Ravikrishnan, A., Jiang, M., Andreadis, S. T., Pfeifer, B. A., & Cheng, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.063 · Cited by 73
Qiao, C.-M., Liu, J., Yang, J., Li, Y., Weng, J., Shao, Y., & Zhang, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.054 · Cited by 72
Regulation of DNA-Raised Immune Responses by Cotransfected Interferon Regulatory Factors
Sasaki, S., Amara, R. R., Yeow, W.-S., Pitha, P. M., & Robinson, H. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6652-6659.2002 · Cited by 71
Concha‐Benavente, F., Srivastava, R. M., Ferrone, S., & Ferris, R. L. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.05.008 · Cited by 70
Pielak, R. M., O’Donoghue, G. P., Lin, J. J., Alfieri, K. N., Fay, N. C., Low-Nam, S. T., & Groves, J. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613140114 · Cited by 69
The contribution of NF‐κB signalling to immune regulation and tolerance
van Delft, M. A. M., Huitema, L. F. A., & Tas, S. W. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12430 · Cited by 68
DNA Vaccines: Regulatory Considerations and Safety Aspects
Myhr, A. I. (2016) · Current Issues in Molecular Biology · doi:10.21775/cimb.022.079 · Cited by 67
Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis
Wolfram, R. K., Heller, L., & Csük, R. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.031 · Cited by 67
Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
Kiyotani, K., Chan, T., & Nakamura, Y. (2017) · Cancer Science · doi:10.1111/cas.13498 · Cited by 64
Elizaga, M. L., Li, S. S., Kochar, N. K., Wilson, G. J., Allen, M., Tieu, H., Frank, I., Sobieszczyk, M. E., Cohen, K. W., Sanchez, B., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202753 · Cited by 63
Bros, M., Ross, X.-L., Pautz, A., Reske‐Kunz, A. B., & Ross, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1825 · Cited by 62
Self-citationPrognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
Yan, X., Zhang, S., Deng, Y., Wang, P., Hou, Q., & Xu, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01050 · Cited by 62
Ross, R., Sudowe, S., Beisner, J., Ross, X.-L., Ludwig‐Portugall, I., Steitz, J., Tüting, T., Knop, J., & Reske‐Kunz, A. B. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301968 · Cited by 61
Xu, Y., Liang, W., Qiu, Y., Cespi, M., Palmieri, G. F., Mason, A. J., & Lam, J. K. W. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00338 · Cited by 61
Coban, C., Kobiyama, K., Jounai, N., Tozuka, M., & Ishii, K. J. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25893 · Cited by 58
Wischhusen, J., Waschbisch, A., & Wiendl, H. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.07.005 · Cited by 58
Development, characterization and cancer targeting potential of surface engineered carbon nanotubes
Mehra, N. K., & Jain, N. K. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.813028 · Cited by 57
Distribution of ATPase-positive Langerhans cells in normal adult human skin
CHEN, H., YUAN, J., Wang, Y., & Silvers, W. K. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb02406.x · Cited by 57
Aerosol Delivery of DNA/Liposomes to the Lung for Cystic Fibrosis Gene Therapy
Davies, L. A., Nunez-Alonso, G. A., McLachlan, G., Hyde, S. C., & Gill, D. R. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/hum.2014.019 · Cited by 56
Optimizing cationic and neutral lipids for efficient gene delivery at high serum content
Chan, C.-L., Ewert, K. K., Majzoub, R. N., Yeu-Kuang, H., Liang, K. S., Leal, C., & Safinya, C. R. (2014) · The Journal of Gene Medicine · doi:10.1002/jgm.2762 · Cited by 55
Xiong, L., & Qiao, S. (2016) · Nanoscale · doi:10.1039/c6nr06777h · Cited by 53
Prazeres, D. M. F., & Monteiro, G. A. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0022-2014 · Cited by 52
Integration of drug, protein, and gene delivery systems with regenerative medicine
Lorden, E. R., Levinson, H., & Leong, K. W. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0165-8 · Cited by 49
Fernando, G. J. P., Zhang, J., Ng, H.-I., Haigh, O. L., Yukiko, S. R., & Kendall, M. A. F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.045 · Cited by 48
Li, S. S., Kochar, N. K., Elizaga, M. L., Hay, C. M., Wilson, G. J., Cohen, K. W., Rosa, S. C. D., Xu, R., Ota‐Setlik, A., Morris, D. E., et al. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00263-17 · Cited by 48
Dendritic Cell Interactions with Lymphatic Endothelium
Russo, E., Nitschké, M., & Halin, C. (2013) · Lymphatic Research and Biology · doi:10.1089/lrb.2013.0008 · Cited by 47
Dresch, C., Edelmann, S. L., Marconi, P., & Brocker, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4495 · Cited by 47
Morán, M. C., Rosell, N. V. I. B., Ruano, G., Busquets, M. A., & Vinardell, M. P. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.009 · Cited by 46
Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination
Lauterbach, H., Gruber, A., Ried, C., Cheminay, C., & Brocker, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4600 · Cited by 46
Levin, Y., Kochba, E., Shukarev, G., Rusch, S., Herrera‐Taracena, G., & Damme, P. V. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.008 · Cited by 46
Ukawa, M., Akita, H., Hayashi, Y., Ishiba, R., Tange, K., Arai, M., Kubo, K., Higuchi, Y., Shimizu, K., Konishi, S., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300629 · Cited by 45
Hoppes, R., Oostvogels, R., Luimstra, J. J., Wals, K., Toebes, M., Bies, L., Ekkebus, R., Rijal, P., Celie, P. H. N., Huang, J. H. Y., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400800 · Cited by 45
Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers
Frenz, T., Grabski, E., Durán, V., Hozsa, C., Stępczyńska, A., Furch, M., Gieseler, R. K. H., & Kalinke, U. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.008 · Cited by 44
In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity
Bins, A. D., Wolkers, M. C., van den Boom, M. D., Haanen, J. B. A. G., & Schumacher, T. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2126 · Cited by 43
Khalil, I. A., & Harashima, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.007 · Cited by 43
Inorganic Nanoparticles As Potential Regulators of Immune Response in Dendritic Cells
Fogli, S., Montis, C., Paccosi, S., Silvano, A., Michelucci, E., Berti, D., Bosi, A., Parenti, A., & Romagnoli, P. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0061 · Cited by 42
Li, Z., Xiong, F., He, J., Dai, X., & Wang, G. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.012 · Cited by 39
Drug delivery across length scales
Delcassian, D., Patel, A. K., Cortinas, A. B., & Langer, R. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1438440 · Cited by 39
Recent Advances in the Rational Design of silica-based Nanoparticles for Gene Therapy
Niu, Y., Popat, A., Yu, M., Karmakar, S., Gu, W., & Yu, C. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.98 · Cited by 38
Eleveld-Trancikova, D., Triantis, V., Moulin, V., Looman, M. W. G., Wijers, M., Fransen, J. A. M., Lemckert, A. A. C., Havenga, M. J. E., Figdor, C. G., Janssen, R. A. J., et al. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804441 · Cited by 38
Recent Advances in Design of Immunogenic and Effective Naked DNA Vaccines Against Cancer
Fioretti, D. P., Iurescia, S., & Rinaldi, M. (2013) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574891x113089990037 · Cited by 37
Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function
Pasqua, L., Leggio, A., Sisci, D., et al. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160321113620 · Cited by 37
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma
Lopes, A., Vanvarenberg, K., Véronique Préat, A., & Vandermeulen, G. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.07.011 · Cited by 37
Jiao, H., Yang, H., Zhao, D., Chen, J., Zhang, Q., Liang, J., Yin, Y., Kong, G., & Li, G. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.006 · Cited by 36
Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination
Glass, J. J., Kent, S. J., & Rose, R. D. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1141054 · Cited by 35
Mancha-Agresti, P. D. C., de Castro, C. P., dos Santos, J. S. C., Araujo, M. A., Pereira, V. B., LeBlanc, J. G., Leclercq, S. Y., & Azevedo, V. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01263 · Cited by 35
Aerosolized Medications for Gene and Peptide Therapy
Laube, B. L. (2015) · Respiratory Care · doi:10.4187/respcare.03554 · Cited by 34
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
Maslow, J. N. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1358325 · Cited by 34
Chappuis, F., Farinelli, T., Deckx, H., Sarnecki, M., Go, O. T., Salzgeber, Y., & Stals, C. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.01.031 · Cited by 33
Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases
Zhang, N., & Nandakumar, K. S. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.062 · Cited by 32
Interferon regulatory factor‐1 acts as a powerful adjuvant in tat DNA based vaccination
Castaldello, A., Sgarbanti, M., Marsili, G., Brocca‐Cofano, E., Remoli, A. L., Caputo, A., & Battistini, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22169 · Cited by 31
Haidari, G., Cope, A. V., Miller, A., Venables, S., Yan, C., Ridgers, H., Reijonen, K., Hannaman, D., Spentzou, A., Hayes, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13331-1 · Cited by 31
Delineating the Cellular Mechanisms Associated with Skin Electroporation
Schultheis, K., Smith, T. R. F., Kiosses, W. B., Kraynyak, K. A., Wong, A., Oh, J., & Broderick, K. E. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.105 · Cited by 31
Trial watch: DNA-based vaccines for oncological indications
Pierini, S., Perales-Linares, R. F., Uribe‐Herranz, M., Pol, J. G., Zitvogel, L., Kroemer, G., Facciabene, A., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1398878 · Cited by 30
Zhang, L., Yang, W., Hu, C., Wang, Q., & Wu, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s154743 · Cited by 29
Cited by
Immunological considerations for COVID-19 vaccine strategies
Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015
COVID-19 Vaccine: A comprehensive status report
Kaur, S. P., & Gupta, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198114 · Cited by 852
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Kyriakidis, N. C., López-Cortés, A., González, E. V., Grimaldos, A. B., & Prado, E. O. (2021) · npj Vaccines · doi:10.1038/s41541-021-00292-w · Cited by 698
A systematic review of SARS-CoV-2 vaccine candidates
Dong, Y., Dai, T., Wei, Y., Zhang, L., Zheng, M., & Zhou, F. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00352-y · Cited by 545
Self-amplifying RNA vaccines for infectious diseases
Bloom, K., van den Berg, F., & Arbuthnot, P. (2021) · Gene Therapy · doi:10.1038/s41434-020-00204-y · Cited by 487
Metadata
- Authors
- Hobernik, D., & Bros, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-11-15
- Volume
- 19
- Issue
- 11
- Pages
- 3605
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2900898034
- Cited by
- 457
- References
- 227
- FWCI
- 18.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.